Clenbuterol Yohimbine – Helio Clen® 40mcg & 5.5mg Cutting Blend

Helio Clen® Blend 5.5 by Beligas — 10 mL multi-dose vial

Helio Clen® Yohimbine 40mcg & 5.5mg is a Beligas stimulant and thermogenic blend built around two adrenergic compounds: clenbuterol and yohimbine. The supplied product label presents 40mcg of clenbuterol with 5.5mg of yohimbine in a 10 mL multi-dose vial.

The combination is better understood as a cutting-focused stimulant blend, not an anabolic steroid. Clenbuterol acts mainly as a beta-2 adrenergic agonist. Yohimbine acts mainly as an alpha-2 adrenergic antagonist. Together, they create a strong sympathetic profile that explains the product’s interest in bodybuilding cutting discussions.

The focus keyword Clenbuterol Yohimbine fits this product because it clearly describes both active ingredients. The concentration on the vial is product information only. It should not be treated as a personal dose or injection plan.

What Is Helio Clen® Yohimbine 40mcg & 5.5mg?

Helio Clen® Blend 5.5 is a Beligas injectable product that combines clenbuterol and yohimbine in one vial. The box identifies it as a 10 mL multi-dose product for use under medical supervision.

Clenbuterol is a long-acting beta-2 agonist. Yohimbine is an alpha-2 adrenergic antagonist. Their mechanisms are different, which is why Clenbuterol Yohimbine blends are often discussed as dual-pathway thermogenic products rather than as single-ingredient stimulants.

The product is also distinct from anabolic steroids. Clenbuterol is not an anabolic-androgenic steroid, even though it appears in bodybuilding and anti-doping discussions because of its performance and body-composition effects.

Helio Clen® Yohimbine Quick Facts

Product Detail	Information
Product Name	Helio Clen® Blend 5.5
Brand	Beligas Pharmaceuticals
Active Ingredients	Clenbuterol 40mcg + Yohimbine 5.5mg
Vial Size	10 mL multi-dose vial
Classification	Stimulant / Thermogenic Compound
Clenbuterol Half-Life	Product-listed 36–48 hours; published human data ~35 hours
Yohimbine Half-Life	About 1–2 hours; published human studies show substantial variability
Water Retention	No
Aromatization	No
Acne	Possible
Primary Bodybuilding Interest	Cutting, thermogenic activity, training drive, leaner appearance

The most important specification is the ingredient pair. Clenbuterol Yohimbine combines a long-acting beta-2 agonist with a much shorter-acting alpha-2 antagonist. That difference matters when discussing duration and stimulant load.

Why the Clenbuterol + Yohimbine Combination Is Different

The blend works through two different adrenergic pathways. Clenbuterol stimulates beta-2 receptors. Yohimbine blocks alpha-2 receptors. This creates a wider sympathetic effect than either ingredient alone.

A human clenbuterol pharmacokinetic study reported a plasma half-life of about 35 hours. A human yohimbine pharmacokinetic study found much faster elimination, generally within a few hours.

This mismatch is important. The yohimbine effect may fade while clenbuterol remains active. That is one reason a fixed-ratio Clenbuterol Yohimbine product should not be treated like two short-acting stimulants with identical timing.

Clenbuterol vs Yohimbine – What Each Ingredient Adds

Feature	Clenbuterol	Yohimbine
Main receptor action	Beta-2 adrenergic agonist	Alpha-2 adrenergic antagonist
Duration	Long acting	Short acting
Main cutting interest	Thermogenesis and metabolic stimulation	Norepinephrine signaling and fat-mobilization interest
Published half-life	About 35 hours in human data	Roughly 0.6–2.5 hours in human studies
Key caution	Prolonged cardiovascular stimulation	Blood-pressure, anxiety and interaction concerns

A recent review of yohimbine describes its alpha-2 antagonism and rapid pharmacokinetics. Evidence for weight-loss outcomes remains limited and variable, so the mechanism should not be presented as a guaranteed result.

Helio Clen® Benefits Discussed During Cutting

Clenbuterol Yohimbine is mainly discussed during calorie-deficit phases. The product’s appeal comes from stimulant activity, thermogenic signaling and a no-aromatization profile rather than direct anabolic-steroid action.

• Thermogenic profile: Clenbuterol can increase sympathetic and beta-2 activity.
• Training drive: The stimulant effect may increase alertness and workout energy.
• Leaner appearance: The product is not associated with aromatization or water retention.
• Cutting-phase interest: Bodybuilding communities discuss the blend when body-fat reduction is the main goal.
• Dual adrenergic action: The two compounds act through different receptor systems.

Yohimbine is often promoted for stubborn-fat areas, but human weight-loss evidence is not strong enough to guarantee that effect. The NIH Office of Dietary Supplements notes that research on yohimbine for weight loss is mixed.

Helio Clen® Results – What Can Shape Progress?

Visible results from Clenbuterol Yohimbine cannot be separated from diet and training. A calorie deficit remains the main driver of fat loss.

• Calorie control: Energy balance has the largest effect on body-fat change.
• Training consistency: Resistance work can help preserve training performance during a cut.
• Cardio volume: Activity level changes total daily energy expenditure.
• Sleep and recovery: Poor sleep can make a stimulant-heavy cutting phase harder to manage.
• Stimulant tolerance: Response to clenbuterol and yohimbine varies widely.
• Product authenticity: The actual ingredient content must match the label for any expected effect.

Because water retention is not a defining feature of this product, users may look for a tighter appearance. That does not mean every change is caused by the blend itself.

Real-World Experience – What Bodybuilding Communities Report

Recent bodybuilding discussions about injectable clenbuterol/yohimbine blends describe a noticeably stronger stimulant feel than many users expect. Common reports include more sweating, a short burst of energy from yohimbine, appetite changes and a longer background stimulant effect from clenbuterol.

The same discussions also show wide variation. Some users report shakiness, elevated heart rate or anxiety, while others describe only mild stimulation. A 2026 community thread on injectable Clen/Yohimbine illustrates how inconsistent individual responses can be.

These reports are not clinical evidence. They are useful only as real-world context. GainBuilt Fitness should present them as community experience, not as proof that Clenbuterol Yohimbine will produce a specific amount of fat loss.

Clenbuterol Yohimbine Dosage – Bodybuilding Community Discussion

Bodybuilding forums often discuss standalone clenbuterol in microgram-level daily ranges and standalone yohimbine in low-milligram ranges. Commonly cited discussions include roughly 20–120mcg/day for clenbuterol and 5–20mg/day for yohimbine. These are anecdotal figures, not approved dosing instructions.

Helio Clen is different because both ingredients are combined in one fixed-ratio vial. Standalone ranges should not be converted into a personal injection amount. The label concentration is product information only.

Clenbuterol has a long human half-life, while yohimbine clears much faster. Repeated exposure can therefore create a changing stimulant balance over time. Medical supervision is especially important with a two-stimulant product.

GainBuilt Fitness provides dosage figures only as general educational material under its Medical Disclaimer.

Helio Clen® Cycle – Common Bodybuilding Discussion

A Helio Clen cycle usually refers to a short cutting period discussed in bodybuilding communities. Clenbuterol forums commonly mention short blocks ranging from about two to six weeks. Some discussions also use two-week on/off patterns.

These practices are not validated medical protocols. They also cannot be copied directly to a fixed Clenbuterol Yohimbine injection because the two ingredients have very different half-lives.

Longer exposure does not guarantee better results. The long persistence of clenbuterol makes cumulative stimulant load more important than the calendar length alone. Diet, cardio, training, recovery and cardiovascular health remain separate factors.

Clenbuterol Yohimbine Half-Life

Clenbuterol lasts far longer than yohimbine. The product information lists roughly 36–48 hours for clenbuterol and 1–2 hours for yohimbine.

Human research estimates the clenbuterol plasma half-life at about 35 hours. Yohimbine studies report an elimination half-life ranging from about 0.6 hours to roughly 2.5 hours, although its active 11-hydroxy metabolite can persist longer.

This difference is one of the most important facts about Clenbuterol Yohimbine. The short yohimbine component can fade while clenbuterol remains active well into the next day.

Half-life should not be confused with detection time or a dosing interval. It only describes how quickly drug levels decline.

Helio Clen® Yohimbine Side Effects

Both active ingredients affect the sympathetic nervous system. Their combined stimulant load makes cardiovascular and neurological effects more important than steroid-style side effects.

• Rapid heartbeat or palpitations: Possible with clenbuterol and yohimbine stimulation.
• Tremor or shakiness: Frequently reported with clenbuterol exposure.
• Blood-pressure changes: Yohimbine can increase norepinephrine and may raise blood pressure in susceptible users.
• Anxiety or restlessness: Yohimbine can produce a strong central stimulant response.
• Sleep problems: The long clenbuterol half-life can make late-day stimulation last longer.
• Sweating, headache or nausea: These are commonly discussed stimulant effects.

The DEA’s 2026 clenbuterol factsheet notes significant cardiovascular and neurological risks, and NCCIH links yohimbine exposure with blood-pressure problems, arrhythmias and seizures.

Product profile: Water retention — No. Aromatization — No. Acne — Possible. Acne is not a defining pharmacologic effect of either ingredient and may vary by individual.

Heart Rate, Blood Pressure and Stimulant Load

The main safety issue with Clenbuterol Yohimbine is not liver toxicity or aromatization. It is the combined adrenergic load.

Clenbuterol can produce prolonged tachycardia, tremor and electrolyte changes. Yohimbine can increase norepinephrine and may worsen anxiety or blood-pressure problems. The combination may feel stronger than either ingredient alone.

A 2026 FDA safety notice involving undeclared yohimbine specifically warns that yohimbine can cause severe high blood pressure, irregular heartbeat and other serious effects, with greater risk alongside other stimulants.

Is Helio Clen® an Anabolic Steroid?

No. Helio Clen is not an anabolic-androgenic steroid. Clenbuterol is a beta-2 adrenergic agonist. Yohimbine is an alpha-2 adrenergic antagonist.

The product appears in bodybuilding because of cutting and performance interest. That does not change its pharmacologic classification.

This distinction is important for SEO and medical accuracy. Some competitor pages incorrectly place clenbuterol under “steroids” or describe it as a steroid. GainBuilt Fitness should keep Clenbuterol Yohimbine clearly classified as a stimulant / thermogenic blend.

How to Check Authentic Beligas Helio Clen® Blend 5.5

The supplied product image shows several details that can help confirm the correct Beligas item. Packaging alone cannot prove authenticity, but the listing and physical product should match.

• Product name: Helio Clen® Blend 5.5
• Brand: Beligas Pharmaceuticals
• Vial size: 10 mL multi-dose vial
• Active ingredients: Clenbuterol 40mcg + Yohimbine 5.5mg
• Packaging: White carton with black and yellow upper band
• Labeling: Rx-only and “for IM use under medical supervision only” text
• Security features: Manufacturer authorization / security verification area on the side panel
• Batch details: Lot and expiry information should be readable and consistent

The product can also be cross-checked against the Beligas Pharmaceuticals brand page on GainBuilt Fitness.

Helio Clen® Yohimbine Price – What Affects Cost?

The price of Clenbuterol Yohimbine blends can vary by manufacturer, vial size, warehouse, current stock and product verification. A price should only be added to this page when the live GainBuilt listing is confirmed.

For Helio Clen Blend 5.5, the value comparison should focus on the exact Beligas product: 10 mL vial, labeled ingredient strengths, intact packaging, batch details and current availability.

Very low pricing should not be treated as a quality signal. Competitor sites often compete heavily on discounts, but authenticity and product identity are more useful long-term trust signals.

Where to Find Helio Clen® Yohimbine Product Information

A clear Clenbuterol Yohimbine listing should show the manufacturer, both active ingredients, vial size, concentration, packaging and legal access requirements.

GainBuilt Fitness can provide product specifications and current availability for Beligas Helio Clen where appropriate. Related cutting and body-composition products can be reviewed in the Weight Loss section.

Clenbuterol is not FDA-approved for human use in the United States. The DEA 2026 clenbuterol document states that FDA has never approved it for human use because of safety concerns. Any product access must follow applicable law and medical requirements.

Why Choose GainBuilt Fitness for Helio Clen® Product Details?

GainBuilt Fitness can present Helio Clen with the product details that many competitor pages leave unclear. The goal is to make the exact blend easy to understand before any order decision.

• Clear ingredient identity: Clenbuterol and yohimbine are listed separately.
• Exact product strength: 40mcg + 5.5mg are shown clearly.
• Beligas branding: Manufacturer information is easy to confirm.
• Product image matching: The listing can be checked against the vial and carton.
• Evidence-based safety context: Medical and regulatory facts are linked to authoritative sources.
• Order support: Eligible orders can be followed through GainBuilt support tools.

After an eligible order is accepted, customers can use Order Tracking for shipment updates.

Competitive Sports and Anti-Doping Status

Athletes subject to anti-doping rules should treat this product as prohibited. The 2026 WADA Prohibited List prohibits beta-2 agonists at all times except for narrow inhaled exceptions that do not include clenbuterol.

Because Helio Clen contains clenbuterol, the product is not suitable for drug-tested sport. The presence of yohimbine does not change that status.

LSI Used: Clenbuterol WADA 2026, Helio Clen competition athletes, Clenbuterol Yohimbine anti-doping, beta-2 agonist prohibited

Frequently Asked Questions About Helio Clen® Yohimbine

Does Helio Clen contain an anabolic steroid?

No. The blend contains clenbuterol and yohimbine. Neither is an anabolic-androgenic steroid.

Why does the clenbuterol component last much longer?

Human pharmacokinetic data place clenbuterol around a 35-hour half-life, while yohimbine usually clears from plasma within a few hours.

Does Helio Clen cause water retention?

Water retention is not a typical feature of this blend, and neither ingredient aromatizes into estrogen.

Is the 40mcg + 5.5mg label a personal dose?

No. It describes the labeled product strength. A fixed blend should not be converted into a personal dose from forum charts.

Can Helio Clen be used by tested athletes?

Clenbuterol is prohibited under the 2026 WADA rules, so the blend is not compatible with drug-tested competition.

Why is product verification important with injectable blends?

Independent testing reports on underground performance products have found mislabeled or missing ingredients in some samples. Packaging, batch information and trusted sourcing therefore matter.

Is yohimbine proven to cause major weight loss?

No. Human research is mixed, and NIH reviews do not support a guaranteed weight-loss claim for yohimbine.

Final View on Helio Clen® Yohimbine 40mcg & 5.5mg

Helio Clen® Blend 5.5 is a Beligas dual-stimulant product combining a long-acting beta-2 agonist with a short-acting alpha-2 antagonist. Its main bodybuilding interest is cutting and thermogenic support, not anabolic-steroid action. The most useful product facts are the 40mcg + 5.5mg label, 10 mL vial, different ingredient half-lives, low water-retention profile and strong stimulant safety considerations. Accurate labeling, legal access and medical oversight matter more than aggressive fat-loss claims.